0
Abstract: Poster Presentations |

CARDIO-PULMONARY MEDICAL HISTORY AND THE EFFECT ON CLINICAL OUTCOME OF COMMUNITY-ACQUIRED PNEUMONIA INFECTIONS TREATED WITH GEMIFLOXACIN FREE TO VIEW

I. Morrisey, MD; T.M. File Jr., MD; L.A. Mandell, MD; G.S. Tillotson, MS*
Author and Funding Information

Oscient, Waltham, MA


Chest


Chest. 2005;128(4_MeetingAbstracts):372S-b-373S. doi:10.1378/chest.128.4_MeetingAbstracts.372S-b
Text Size: A A A
Published online

Abstract

PURPOSE:  Gemifloxacin is a potent new fluoroquinolone with excellent activity against community-acquired pneumonia (CAP) pathogens.

METHODS:  Pooled data from 5 phase III CAP gemifloxacin clinical trials were evaluated. Patients were grouped based on cardio-pulmonary disease and medical history (CPD). Clinical response (success or failure) at end of therapy (EOT) & at follow-up (FU, approx. 1-3 weeks after treatment) was studied. Main comparators for CPD patients were cefuroxime & clarithromycin (97 patients), trovafloxacin (66 patients) & amoxicillin-clavulanate (55 patients).

RESULTS:  Percent success is shown in the table (* includes all 3 CPD groups in table plus patients with a medical history of angina, pulmonary heart disease, cardiomyopathy, cardiac murmurs, tachycardia or myocardial infarction).

CONCLUSION:  Although in general, gemifloxacin showed slightly lower success than pooled comparators against CAP patients, gemifloxacin showed higher success rates than comparator against CPD patients.This difference was greater at FU than at EOT.

CLINICAL IMPLICATIONS:  These data support the use of gemifloxacin in the treatment of CAP, especially where the patient has a history of CPD. CPD groupTreatment% Success (Number of patients)EOTFUCAP AllGemifloxacin86.9% (1166)80.9% (1164)Comparator87.2% (933)81.6% (928)ALL CPD*Gemifloxacin88.8% (356)82.9% (356)

DISCLOSURE:  GS Tillotson, Grant monies (from industry related sources) Oscient; Shareholder Oscient; Employee Oscient; Consultant fee, speaker bureau, advisory committee, etc. Oscient.

Wednesday, November 2, 2005

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543